Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 14/20 | 0.54 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.50 |
| ▸ | NQO2 | P16083 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.47 |
| ▸ | HTR1B | P28222 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8961217 | 0.95 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2HTR1AHTR1B | |
| SCHEMBL8961285 | 0.88 | MTNR1A (0.56) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8961222 | 0.87 | MTNR1A (0.71) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8961269 | 0.86 | MTNR1A (0.57) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8961088 | 0.85 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8960863 | 0.85 | MTNR1A (0.57) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8065738 | 0.83 | MTNR1A (0.52) | MTNR1AMTNR1BNQO2HTR1AHTR1B | |
| SCHEMBL8960838 | 0.83 | MTNR1A (0.58) | MTNR1AMTNR1BNQO2 | |
| SCHEMBL8961055 | 0.83 | MTNR1A (0.73) | MTNR1AMTNR1BNQO2HTR2CHTR2B | |
| SCHEMBL8961119 | 0.82 | MTNR1A (0.65) | MTNR1AMTNR1BNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5552418-A | FOR TREATING DISORDERS OF THE MELATONINERGIC SYSTEM | ADIR ET COMPAGNIE (FR) | 1996-09-03 | — | — | US | disclosed |